| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by investing activities | 85,140 | 60,469 |
| Proceeds from issuance of common stock and espp | 120 | 120 |
| Net cash provided by financing activities | 120 | 120 |
| Net (decrease) increase in cash, cash equivalents, and restricted cash | -2,539 | -1,626 |
| Cash and cash equivalents at beginning of period | 61,213 | - |
| Cash and cash equivalents at end of period | 58,674 | - |
Century Therapeutics, Inc. (IPSC)
Century Therapeutics, Inc. (IPSC)